Inflammation in Cardiovascular Disease

This publication has 26 references indexed in Scilit:

• Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
  New England Journal of Medicine, 1997
• Elaboration of Type-1 Plasminogen Activator Inhibitor From Adipocytes
  Circulation, 1996
• The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
  New England Journal of Medicine, 1994
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction
  The Lancet, 1993
• Fibrinogen and risk of cardiovascular disease. The Framingham Study
  JAMA, 1987
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• Raised C-reactive protein levels in serum from smokers
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1985
• C-REACTIVE PROTEIN FIFTY YEARS ON
  The Lancet, 1981
• The Concentration of C-Reactive Protein in Sera from Healthy Individuals
  Scandinavian Journal of Clinical and Laboratory Investigation, 1972